Health ❯ Vaccination ❯ Vaccine Development

COVID-19 Vaccines

JN.1 Variant Variant-Specific Vaccines Efficacy

U.S. Summer COVID Wave Grows as HHS Limits Fall Booster Eligibility

Development of fall JN.1 boosters proceeds under new trial mandates excluding most adults and healthy children.

New COVID Variant NB.1.8.1 Monitored in U.S. After Driving Surges in Asia